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Objective: Intravenous or intraspinal transplantation of human umbilical cord blood cells-derived CD34þ
cells (human CD34þ cells) or mesenchymal stem cells after spinal cord injury (SCI) improved hind limb
functional recovery in adult rats. The objective of this study is to ascertain whether SCI in rats can be
attenuated by conditioned medium (CM) or secretome obtained from cultured human CD34þ stem cells.
Materials and methods: Sprague-Dawley rats were assigned to one of the following ﬁve groups: the sham
group, the SCI group treated with vehicle solution (SCI þ V), the SCI group treated with CM (SCI þ CM),
the SCI group treated with 17b-estradiol E2 (10 mg; SCI þ E2), and the SCI group treated with CM plus E2
(SCI þ CM þ E2). A 0.5-mL volume of CM or vehicle solution was administered intravenously immediately
after SCI.
Results: Compared with the sham group, the (SCI þ V) group had signiﬁcantly higher scores of neuro-
logical motor dysfunction as well as inﬂammation apoptosis, oxidative stress, and astrogliosis in the
injured spinal cord. The neurological deﬁcits, numbers of apoptotic cell, extent of inﬂammation, oxidative
stress, and astrogliosis in the injured spinal cord were signiﬁcantly attenuated by CM, E2, or CM plus E2,
but not by the vehicle solution. In addition, the neuroprotective effect exerted by a combination of CM
and E2 is superior to that exerted by CM- or E2-alone therapy.
Conclusion: The neuroprotective effects of CM from cultured human CD34þ cells are similar to those of
human CD34þ cells and the CM was found to enhance the neuroprotective effects of E2 in rat SCI.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Intravenous [1] or intraspinal [2,3] transplantation of human
umbilical cord blood cells (HUCBCs)-derived CD34þ cells (human
CD34þ cells) or mesenchymal stem cells [4] after spinal cord injury
(SCI) improved hind limb functional recovery in adult rats. Evi-
dence has accumulated to suggest that paracrine mechanisms
mediated by factors released by the stem cells may mediate then Hospital, 167, Section 3, Jin
.
bstetrics & Gynecology. Published bbeneﬁcial effects observed after stem cell infusion in brain damage
[5e7]. Cantinieaux et al [8] reported that conditionedmedium (CM)
from bone marrow-derived mesenchymal stem cells (BMSCs) im-
proves recovery after SCI in rats. In that study, BMSCeCM or control
medium was injected into the lesion site via a Hamilton micro-
syringe. However, it is not known whether intravenous adminis-
tration of CM from cultured human CD34þ cells is able to protect
against outcomes of SCI in rats.
It has previously been shown that estrogen treatment improves
functional outcome in acute or chronic SCI [9e11]. Again, it is not
known whether the neuroprotective effects of 17b-estradiol in SCI
can be enhanced signiﬁcantly by simultaneous application of the
CM derived from human CD34þ cells.y Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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Figure 1. Effect of human umbilical cord blood cell conditioned medium (CM) from
human CD34þ cells and 17b-estradiol on functional recovery following spinal cord
injury (SCI). Functional recovery was assessed by Basso, Beattie, and Bresnahan (BBB)
behavioral testing, which began 1 day after injury and then continued for 7 days. Rats
with SCI were treated with vehicle (B), CM (C), 17b-estradiol (D), or a combination of
CM and 17b-estradiol (E) immediately after the injury as described in the “Materials
and Methods” section. Data are presented as mean ± standard deviation (n ¼ 8 for each
group). The vehicle treatment after SCI (B) signiﬁcantly decreased the BBB scores as
compared with the values in the sham group (A). *p < 0.001. CM (C) or 17b-estradiol
(D) treatment after SCI signiﬁcantly increased the BBB scores as compared with those
in the vehicle-treated control (B), **p < 0.05 or p < 0.01. Combined CM and 17b-
estradiol (E) treatment signiﬁcantly increased the BBB scores as compared with those
in the “C” group or in the “D” group, ***p < 0.05.
C.-H. Yeng et al. / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 85e9386The primary aim of this study was to evaluate the temporal
proﬁles of injured spinal cord in rats with neurological motor
deﬁcits and neuronal apoptosis, inﬂammation, oxidative stress, and
astrogliosis without or with CM, E2, or CM plus E2 treatment. The
secondary aim was to determine whether the beneﬁcial effects of
CM plus E2 in reducing neurological motor deﬁcits and spinal cord
apoptosis, inﬂammation, oxidative stress, and astrogliosis are su-
perior to those of CM or E2 alone.
Materials and Methods
Inducing spinal cord contusion
Adult male Sprague-Dawley rats (weight 218 ± 12 g) were ob-
tained from the Animal Resource Center of the National Science
Council of the Republic of China (Taipei, Taiwan). The animals were
housed in groups of four at an ambient temperature of 22 ± 1C
with a 12-hour lightedark cycle. Rat chow (pellets) and tap water
were available ad libitum. All protocols were approved by the Ani-
mal Ethic Committee of the Chi Mei Medical Center (Tainan,
Taiwan), in accordance with the Guidelines for the Care and Use of
Laboratory Animals of the National Institutes of Health, and the
Guidelines of the Animal Welfare Act.
A laminectomy with vertebral peduncle removal was per-
formed at T8 or T9 on rats anesthetized with sodium pentobar-
bital (25 mg/kg administered intraperitoneally; Sigma Chemical
Co., St. Louis, MO, USA) and a mixture containing ketamine
[44 mg/kg administered intramuscularly (i.m.); Nankang Phar-
maceutical Co., Taipei, Taiwan], atropine (0.02633 mg/kg i.m.;
Sintong Chemical Industrial Co., Taoyuan, Taiwan), and xylazine
(6.77 mg/kg i.m.; Bayer, Lever Kusen, Germany). The jaws of a
calibrated aneurysm clip with a closing pressure of 55 g were
placed on the dorsal and ventral surfaces of the spinal cord and
left in place for 1 minute [12]. The sham-operated control animals
received the same surgical procedure (laminectomy), but did not
undergo compression. All animals were given 0.1 mL of Baytril
(Bayer, Shawnee Mission, Kansas, USA) antibiotic daily for 3 days
postoperatively. Animals with SCI were individually housed on
special bedding to prevent skin breakdown, and their bowels and
bladders were manually expressed two times daily. Food and
water were freely accessible at a lowered height in their cages.
Human CD34þ cell preparation
Human CD34þ cells were isolated from cord blood using a Direct
CD34þ Progenitor Cell Isolation kit (Miltenyi Biotec, Bergisch
Gladbach, Germany) and CD34þ MultiSort kit (Miltenyi Biotec)
according to the manufacturer's protocol. The detailed procedures
were described previously [13]. Human CD34þ cells were isolated
from the cord blood of seven women after obtaining informed
consent from their mother and Institutional Review Board
approval.
Cell culture and preparation of CM
Human CD34þ cells were cultured in Dulbecco's modiﬁed Ea-
gle's medium (DMEM)-low glucose supplemented with 10% CD34þ
cells-qualiﬁed fetal bovine serum during the entire experimental
period. CM was prepared by collecting serum-free medium (sup-
plemented with 0.05% bovine serum albumin to prevent protein
aggregation) after 72 hours of culture of the cells mass of
1  106 cells. The medium was concentrated, approximately 10-
fold, using ultraﬁltration units (Amicon Ultra-PL 3; Millipore,
Merck, Billerica, Massachusetts, USA) with a 3-kDa molecular mass
cutoff. Cells were cultured under a hypoxic condition. The hypoxicconditionwas achieved with a well-characterized, ﬁnely controlled
proOx-c-chamber system (BioSpherix). The oxygen concentration
in the chamber was maintained at 0.5% with a residual gas mixture
composed of 5% CO2 and balanced nitrogen.Experimental groups
Rats were divided into the following ﬁve groups based on the
treatment they received: (1) the sham-SCI group (rats given a
sham SCI operation); (2) the SCI þ vehicle (V) group [SCI rats
treated with vehicle (DMEM)]; (3) the SCI þ CM group [SCI rats
treated with secretome or CM from the cultured human CD34þ
cells]; (4) the SCIþ E2 group (SCI rats treated with 17b-estradiol E2
(10 mg/mL) in DMEM); and (5) the SCI þ CM þ E2 group [SCI rats
treated with CM plus E2 (10 mg/mL) in DMEM]. DMEM (or vehicle)
or CM at a volume of 0.5 mL was administered via the tail vein
immediately after SCI.Assessing hind limb locomotor function
Starting at 24 hours postinjury and once daily for 3e7 days,
locomotor function was assessed using the Basso, Beattie, and
Bresnahan (BBB) open-ﬁeld locomotor scale, as described previ-
ously [14]. Scoring was performed by two trained technicians
who were blinded to treatments. Locomotor function was
observed for 4 minutes in an open ﬁeld and scored from 0 (no
observable hind limb movements) to 21 (normal locomotion with
consistent plantar stepping and coordinated gait, toe clearance,
parallel paw position, trunk stability, and tail consistency in an
upper position).
C.-H. Yeng et al. / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 85e93 87Tissue preparation
Seven days after SCI, rats were anesthetized with chloral hy-
drate and perfused with 0.1M phosphate-buffered saline (PBS; pH
7.4) and subsequently with 4% paraformaldehyde in 0.1M PBS (pH
7.4) via a cardiac puncture. A 20-mm section of the spinal cord,
centered at the lesion site, was dissected out and postﬁxed by
immersion in 4% paraformaldehyde overnight. Longitudinal sec-
tions were cut at either 10 mm for preparing parafﬁn-embedded
tissues.
Assessment of free radical compounds
The injured spinal cord tissue proper (core region) was removed
and dissected out for determination of malondialdehyde (MDA),
glutathione peroxidase (GPx), glutathione reductase (GR), super-
oxide dismutase (SOD), and catalase contents. Lipid peroxidation
was assessed by measuring the levels of MDAwith 2-thiobarbituric
acid (TBA) to form a chromophore absorbing at 532 nm [15].A B
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Figure 2. Effect of conditioned medium (CM) from human CD34þ cells and 17b-estradiol
vehicle (B), CM (C), 17b-estradiol (D), or a combination of CM and 17b-estradiol (E) immed
Longitudinal sections were processed for terminal deoxynucleotidyl transferase deoxyurid
counted as described in the “Materials and Methods” section. Data are presented as mean ± s
number of TUNEL-positive cells as compared with the positive cells in the sham SCI control (A
number of TUNEL-positive cells as compared with the positive cells in the vehicle-treate
signiﬁcantly decreased the number of TUNEL-positive cells as compared with the positive
TUNEL-positive cells (arrows) 7 days after SCI (as shown in the top panels). Bar ¼ 30 mm.Approximately 0.1 g of spinal cord tissue was homogenized with
1.5 mL of 0.1M phosphate buffer at pH 3.5. The reaction mixture
(0.2 mL of sample, 1.2 mL of 20% acetic acid, 0.2 mL of 8.1% sodium
dodecyl sulfate, and 1.5 mL of aqueous solution of 0.8% of TBA, up to
4 mL with distilled water) was heated to 95C for 1 hour and then
5 mL of N-butanol and pyridine (15:1 vol/vol) were added. The
mixture was vortexed vigorously, centrifuged at 1500g for 10 mi-
nutes, and then the absorbance of the organic phase was measured
at 532 nm. The values were expressed as nanomoles of TBA-
reactive substance (MDA equivalent) per milligram of protein
[16]. To measure cytosolic SOD and catalase activities, tissues were
homogenized in 200nM phosphate buffer (pH 7.0). The homoge-
nates were centrifuged at 3000g for 10 minutes at 4C, and su-
pernatants were used for determining the catalase activity. The
SOD and catalase activities were assessed using an SOD activity
commercial kit (OxisResearch, Portland, OH, USA) and catalase
activity commercial kit (OxisResearch), respectively. Protein con-
centration was determined according to the method suggested by
Lowry et al [17].C D E
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on apoptotic cell death after spinal cord injury (SCI). Rats with SCI were treated with
iately after the injury, and spinal cord tissues were then collected 7 days postinjury.
ine triphosphate nick end labeling (TUNEL) staining, and TUNEL-positive cells were
tandard deviation (n ¼ 3). The vehicle treatment after SCI (B) signiﬁcantly increased the
), *p < 0.001. CM (C) or 17b-estradiol (D) treatment after SCI signiﬁcantly decreased the
d control (B), **p < 0.05 or p < 0.01. Combined CM and 17b-estradiol (E) treatment
cells in the “C” group or in the “D” group, ***p < 0.05. Representative photographs of
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Figure 3. Effect of conditioned medium (CM) from human CD34þ cells and 17b-
estradiol on caspase-3-activity after spinal cord injury (SCI). CM or 17b-estradiol was
administered intravenously to rats immediately after injury and the animals were
killed 3 days after injury. The caspase-3 speciﬁc activity was signiﬁcantly enhanced in
SCI animals treated with vehicle solution (B) as compared with sham-SCI controls (A).
Values represent mean ± standard deviation (n ¼ 3/group). Caspase-3 activity was
signiﬁcantly reduced in SCI rats receiving CM (C) or 17b-estradiol (D) treatment as
compared with vehicle-treated SCI rats. Caspase-3 activity was signiﬁcantly reduced in
SCI rats receiving combined CM and 17b-estradiol (E) treatment as compared with CM-
treated (C) or 17b-estradiol-treated (D) SCI rats. *p < 0.001, **p < 0.05, and ***p < 0.01.
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liquid chromatography-nitric oxide detector system (ENO-10;
Eicom, Kyoto, Japan), as reported previously [18]. In brief, nitrite and
nitrate were separated on a reverse-phase column (No-PAK,
4.6 mm  50 mm; Eicom), and nitrate was reduced to nitrite by
passing it through a reduction column (NO-RED; Eicom). Nitrite was
determined as the azo dye compound formed by the Griess reaction
using a spectrophotometer. These oxidative NO products were also
measured as NOx.
The concentrations of hydroxyl radicals were measured by a
modiﬁed procedure based on the hydroxylation of sodium salicy-
lates by hydroxyl radicals, which leads to the production of 2,3-
dihydroxybenzoic acid (2,3-DHBA) and 2,5-DHBA [19,20]. The
retention times of 2,3-DHBA and 2,5-DHBA were 8.1 minutes and
6.0 minutes, respectively.
Terminal deoxynucleotidyl transferase deoxyuridine triphosphate
nick-end labeling or glial ﬁbrillary acidic protein staining
Seven days after SCI, lesioned (core) spinal cords were prepared
as described earlier. Serial 10-mm longitudinal sections through the
anterior hornwere selected and used for terminal deoxynucleotidyl
transferase deoxyuridine triphosphate nick end labeling (TUNEL)
for the detection of apoptotic cells (nucleotide; Roche, Mannheim,
Germany) or antiglial ﬁbrillary acidic protein (anti-GFAP; Sigma,
1:4000 for the detection of reactive astrocytes). For negative con-
trols, all the procedures were performed in the same way, but
without the primary antibodies. We then colabeled all tissues with
40,6-diamidino-2-phenylindole (DAPI), a nonspeciﬁc nuclear
marker (Vector Laboratories, Burlingame, CA, USA) and expressed
the immunohistochemically positive cells as a ratio to all DAPI-
positive cells. All cell counting was done in a blinded manner to
avoid any bias.
Determining the activities of both caspase-3 and myeloperoxidase
At 7 days after injury, rats (n ¼ 8/group) were anesthetized and
perfused with 0.1M PBS (pH 7.4) via cardiac puncture. Caspase-3
activity was assayed using a procedure described by Springeret al [21,22]. In brief, a segment of spinal cord centered at the
lesioned site was Dounce homogenized in 0.5 mL of homogeniza-
tion buffer (pH 7.4) containing 10mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid, 250mM sucrose, 1mM EDTA, 0.1%
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate,
5mM dithiothreitol, and 10 mL each of 1 mg/mL pepstatin, 2,5 mg/
mL leupeptin, 2 mg/mL aprotinin, and 0.2M phenylmethylsulfonyl
ﬂuoride. The speciﬁc activity of the samples was calculated relative
to a standard curve using recombinant caspase-3 (Upstate
Biotechnology, Lake Placid, NY, USA).
Myeloperoxidase (MPO) activity, an indicator of poly-
morphonuclear leukocyte accumulation, was determined in the
spinal cord tissues as previously described [23]. MPO activity was
deﬁned as the quantity of enzyme degrading 1 mmol of peroxide/
minute at 37C, and is expressed in milliunit/gram of wet tissue.Cytokine assays
Additional animals (n¼ 8 for each time point and for each group)
were subjected to the spinal cord compressionwith or without drug
treatment, and killed 7 days post-SCI. Segments (0.2-cm long) of the
spinal cord containing the epicenter of injury, and the adjacent
rostral and caudal segments were dissected and put in ice-cold
homogenization buffer [PBS containing 1mM EDTA and 1% (vol/
vol) protease inhibitor cocktail from Sigma]. After homogenization
on ice for 10 seconds using a POLYTRON at maximal speed, the ly-
sates were centrifuged at 18,000g for 20 minutes at 4C and the
supernatants were used for cytokine determination. The protein
concentrations were measured using a NanoDrop ND-1000 spec-
trophotometer (NanoDrop Technologies, Wilmington, DE, USA). The
concentrations of interleukin-1b (IL-1b), IL-6, IL-10, and tumor ne-
crosis factor-a (TNF-a) in the samples were determined using the
Bio-Plex Cytokine Assay (Bio-Rad Laboratories). The concentrations
were expressed in picogram/milligram total proteins.Statistical analysis
Data are presented as mean ± standard deviation values.
Quantitative data from open-ﬁeld locomotor scores were evaluated
for statistical signiﬁcance by two-way analysis of variance (ANOVA)
with replications following Duncan test for multiple comparisons;
data from TUNEL-positive cells, GFAP-positive cells, caspase-3 ac-
tivities, and the concentrations of cytokines were evaluated for
statistical signiﬁcance using two-way ANOVAwith a post hoc Tukey
test. In all analyses, a p value of less than 0.05 was considered
statistically signiﬁcant.Results
CM or E2 therapy attenuated SCI-induced neurological and motor
deﬁcits
The effect of CM, E2, or combination of CM and E2 on locomotor
function was determined to see whether CM or E2 had beneﬁcial
effects on functional recovery after SCI. Immediately after SCI, all
injured rats had paralyzed hind limbs. As shown in Figure 1, the BBB
scores were signiﬁcantly higher in rats treated with CM, 17b-
estradiol, or combination of both CM and estradiol 1e7 days after
SCI than in vehicle-treated rats. In addition, rats treated with a
combination of CM and 17b-estradiol had signiﬁcantly higher BBB
scores than those treated with CM or 17b-estradiol alone.
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Acute SCI induces extensive apoptotic cell death of neurons and
glial cells [11,24]. In this study, apoptotic cell death was analyzed by
TUNEL staining. As shown in Figure 2, CM, 17b-estradiol, or a
combination of CM and 17b-estradiol signiﬁcantly reduced the
number of TUNEL-positive cells 7 days after SCI, compared with
those cells in the vehicle control. Rats treatedwith a combination of
CM and 17b-estradiol had signiﬁcantly lower TUNEL-positive cells
than those treated with CM or 17b-estradiol alone.
Caspase-3 activation is involved in apoptotic cell death as a
common executive molecule after SCI [11,24]. As shown in Figure 3,
CM, 17b-estradiol, or a combination of CM and 17b-estradiol
signiﬁcantly reduced speciﬁc caspase-3 activity 7 days after SCI,
compared with that of the vehicle control. Again, rats treated with a
combination of CM and 17b-estradiol had signiﬁcantly lower spe-
ciﬁc caspase-3 activity than those treated with CM or 17b-estradiol
alone.A B C
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Figure 4. Effect of conditioned medium (CM) from human CD34þ cells and 17b-estradiol on
17b-estradiol (D), or a combination of CM and 17b-estradiol (E) immediately after the inju
protein (GFAP)-positive cells in the injured spinal cord are shown in the ﬁrst panel (top row
SCI (B) signiﬁcantly enhanced the number of GFAP-positive cells as compared with the po
treatment after SCI signiﬁcantly reduced the number of GFAP-positive cells as compared wi
CM and 17b-estradiol (E) treatment signiﬁcantly reduced the number of GFAP-positive cells
Representative photographs of GFAP-positive cells (arrows) 3 days after SCI as shown in thCM or E2 therapy attenuated SCI-induced astrogliosis
The expression of GFAP has been shown to be the hallmark of
reactive astrocytes after neurotrauma [25]. As shown in Figure 4,
CM, 17b-estradiol, or a combination of CM and 17b-estradiol
signiﬁcantly reduced the number of GFAP-positive cells 7 days after
SCI as compared with that of the vehicle control. Rats treatedwith a
combination of CM and 17b-estradiol had signiﬁcantly lower GFAP-
positive cells than those treated with CM or 17b-estradiol alone.CM or E2 therapy reduced SCI-induced inﬂammation
Activated inﬂammation (evidenced by increased levels of IL-1b,
TNF-a, and MPO but decreased levels of IL-10) caused by SCI was
noted (Figure 5). Treatment with CM, 17b-estradiol, or a combina-
tion of CM and 17b-estradiol signiﬁcantly reduced the spinal cord
concentration of IL-1b, TNF-a, and MPO 7 days after SCI as
compared with that of the vehicle control (Figure 5). By contrast,
compared with that of vehicle control, CM, 17b-estradiol, or a
combination of CM and 17b-estradiol had higher spinal cord levels
of IL-10 3 days after SCI (Figure 5).D E
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astrogliosis after spinal cord injury (SCI). SCI rats were treated with vehicle (B), CM (C),
ry, and spinal cord tissues were then collected 3 days postinjury. Glial ﬁbrillary acidic
). Data are presented as mean ± standard deviation (n ¼ 3). The vehicle treatment after
sitive cells in the sham SCI control group (A), *p < 0.01. CM (C) or 17b-estradiol (D)
th the positive cells in the vehicle-treated control (B), **p < 0.05 or p < 0.01. Combined
as compared with the positive cells in the “C” group or in the “D” group, ***p < 0.05.
e top panels. Bar ¼ 30 mm. DAPI ¼ 40 ,6-diamidino-2-phenylindole.
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Figure 5. Effect of conditioned medium (CM) from human CD34þ cells (secretome)
and 17b-estradiol on activated inﬂammation after spinal cord injury (SCI). SCI rats
were treated with vehicle (B), CM (C), 17b-estradiol (D), or a combination of CM and
C.-H. Yeng et al. / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 85e9390The beneﬁcial effects of a combination of CM and 17b-estradiol
in reducing SCI-induced inﬂammationwere superior to those of CM
or 17b-estradiol alone (Figure 5).
CM or E2 therapy reduced SCI-induced oxidative stress
Three days after SCI, the injured spinal cord of vehicle-treated
rats showed signiﬁcant oxidative stress as evidenced by increased
levels of nitric oxide, 2,3-DHBA, and MDA but decreased levels of
SOD, GPx, and GR (Figure 6). Treatment with CM,17b-estradiol, or a
combination of CM and 17b-estradiol signiﬁcantly reduced the
oxidative stress caused by SCI. In addition, the beneﬁcial effects a
combination of CM and 17b-estradiol in treating SCI-induced spinal
cord oxidative stress were superior to that of CM or 17b-estradiol
alone (Figure 6).
Discussion
The primary aim of this study was to assess the effect of CM,
17b-estradiol, or CM plus 17b-estradiol on locomotor function
after SCI. Five essential ﬁndings of this study are as follows: (1)
CM- or 17b-estradiol-alone treatment improves functional re-
covery after SCI; (2) CM or 17b-estradiol treatment reduces
apoptotic cell death and caspase-3 activity after SCI; (3) CM or
17b-estradiol treatment attenuates spinal cord activation of as-
trocytes as well as inﬂammation (evidenced by increased spinal
cord levels of IL-1b, TNF-a, and MPO after SCI); (4) treatment
with CM or 17b-estradiol reduces oxidative stress (evidenced by
increased spinal cord levels of nitric oxide, 2,3-DHBA, and MDA
but decreased spinal cord levels of SOD, GP, and GR after SCI);
and (5) treatment with a combination of both CM and 17b-
estradiol displays signiﬁcantly higher beneﬁcial effects in
reducing locomotor dysfunction, apoptotic cell death, astrocy-
tosis, activated inﬂammation, and oxidative stress in injured
spinal cord after SCI than that of CM- or 17b-estradiol-alone
therapy. These results indicate that the beneﬁcial effects of CM or
17b-estradiol treatment may be linked to its neuroprotective
activity against SCI-induced apoptosis, thereby reducing the SCI
and improving functional recovery. Furthermore, our data
showed that the neuroprotective effects of CM or 17b-estradiol
might be mediated in part by the modulation of spinal cord
inﬂammation and oxidative stress after SCI.
Our data provide strong support for a paracrine mechanism
responsible for neuroprotective repair from experiment studies in
which the administration of the secretome from HUCBC-derived
CD34þ cells was able to recapitulate the beneﬁcial effects
observed after stem cell therapy in SCI. These results are in part
consistent with the ﬁndings that CM from BMSCs improves re-
covery after SCI in rats [8]. However, paracrine-mediated actions
have been proposed to explain the beneﬁcial effects of BMSC
transplantation after SCI. They show that, in vitro, BMSCeCM pro-
tects spinal cord neurons from apoptosis, activates macrophages,17b-estradiol (E) immediately after the injury, and spinal cord tissues were then
collected 3 days postinjury. Samples were processed for biochemical assay of inter-
leukin-1b (IL-1b), tumor necrosis factor-a (TNF-a), IL-10, and myeloperoxidase (MPO)
as described in the “Materials and Methods” section. Data are presented as
mean ± standard deviation (n ¼ 8). The vehicle treatment after SCI (B) signiﬁcantly
enhanced the spinal levels of IL-1b, TNF-a, and MPO as compared with those in the
sham SCI control (A). CM (C) or 17b-estradiol (D) treatment after SCI signiﬁcantly
reduced the spinal levels of IL-1b, TNF-a, and MPO but enhanced the spinal levels of IL-
10 as compared with those in the vehicle-treated control (B), **p < 0.05. Combined CM
and 17b-estradiol (E) treatment signiﬁcantly reduced the spinal levels of IL-1b, TNF-a,
and MPO but signiﬁcantly enhanced the spinal levels of IL-10 as compared with those
in the “C” group or in the “D” group, ***p < 0.05.
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Figure 6. Effect of conditioned medium (CM) and 17b-estradiol on oxidative stress after spinal cord injury (SCI). SCI rats were treated with vehicle (B), CM (C), 17b-estradiol (D), or a
combination of CM and 17b-estradiol (E) immediately after the injury, and spinal cord tissues were then collected 3 days postinjury. Samples were processed for biochemical
determination of spinal levels of nitric oxide (NO), 2,3-dihydroxybenzoic acid (2,3-DHBA), malondialdehyde (MDA), superoxide dismutase (SOD), GP, and glutathione reductase (GR)
as described in the “Materials and Methods” section. Data are presented as mean ± standard deviation (n ¼ 8). The vehicle-treatment after SCI (B) signiﬁcantly enhanced the spinal
levels of NO, 2,3-DHBA, MDA but signiﬁcantly reduced the spinal levels of SOD, GP, and GR as compared with those in the sham SCI control group (A), *p < 0.05. CM (C) or 17b-
estradiol (D) treatment after SCI signiﬁcantly reduced the spinal levels of NO, 2,3-DHBA, and MDA but signiﬁcantly enhanced the spinal levels of SOD, GP, and GR as compared with
those in the vehicle-treated control (B), **p < 0.05. Combined CM and 17b-estradiol (E) treatment signiﬁcantly reduced the spinal levels of NO, 2,3-DHBA, and MDA but signiﬁcantly
enhanced the spinal levels of SOD, GP, and GR as compared with those in the “C” group or in the “D” group, ***p < 0.05.
C.-H. Yeng et al. / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 85e93 91and promotes pro-angiogenesis. In vivo, they show that BMSCeCM
administered after spinal cord contusion improves motor recovery.
Histological analysis conﬁrms the Angiogenic action of BMSCeCM
as well as tissue protection effect. Finally, the characterization of
BMSCeCM by cytokine assay and enzyme-linked immunosorbentassay identiﬁed trophic factors as well as cytokine likely involved in
the observed beneﬁcial effects. These results support the paracrine-
mediated mode of action of BMSCs. Therefore, the elucidation of
the factors in the HUCBCeCD34þ cellseCM by mass spectrum is
warranted in future studies.
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fects and attenuates apoptosis in acute [11,26] or in chronic [9] SCI
rats. Here we have further demonstrated that, in addition to stim-
ulating MPO activity (an indicator for accumulation of poly-
morphonuclear cells), SCI animals display higher levels of both
TNF-a and IL-1b in the injured spinal cord, which can be reduced by
estrogen or human CD34þ cells-derived CM treatment. In addition,
estrogen or CM therapy stimulates production of IL-10 (an anti-
inﬂammatory cytokine) in the injured spinal cord. IL-10 has been
shown to protect from endotoxemia by reducing TNF-a release [27].
Neutralization of endogenously produced IL-10 leads to increased
production of proinﬂammatory cytokines and enhancement of
mortality after sepsis [28]. Both an increased likelihood of inﬂam-
matory illness [29] and higher mortality rates after sepsis [30] are
observed in IL-10 knockout mice. Thus, it appears that estrogen or
CM improves outcomes of SCI in rats by stimulating IL-10 produc-
tion but by inhibiting production of proinﬂammatory cytokines
(e.g., IL-1b and TNF-a) as well as acts an indicator of accumulation
of leucocytes (e.g., MPO activity). Our data also show that SCI rats
display signiﬁcantly higher spinal levels of reactive oxygen species
(e.g., nitric oxide and 2,3-DHBA), lipid peroxidation (e.g., MDA), and
enzymatic pro-oxidants (e.g., glutathione oxidized/glutathione
reduced), but lower spinal levels of enzymatic antioxidant defenses
(e.g., GR and GPx) during SCI. We further show that estrogen or CM
attenuates SCI by reducing spinal levels of reactive oxygen species,
lipid peroxidation, and enzymatic pro-oxidants but by enhancing
spinal levels of enzymatic antioxidant defenses. Increased pro-
duction of reactive oxygen species is involved in both activated
inﬂammation and oxidative damage in ischemic brain tissues,
which leads to cell death [31]. Therefore, adjunct therapy of CM
with estrogen provides better therapeutic effects in treating SCI.
Caspases are known to be involved in neuronal apoptosis in
brain injury and neurodegenerative diseases [32e37]. In particular,
caspase-3 has been implicated in apoptotic cell death after SCI
[21,22,38e40]. This study showed that CM or 17b-estradiol treat-
ment reduced not only apoptotic cell death but also caspase-3 ac-
tivity after SCI. This is consistent with the ﬁndings of many
investigators [9,11,41]. However, whether reduced caspase activity
is the cause or result of the neuroprotective effect exerted by CM or
E2 is not apparent.
In summary, human CD34þ cells-derived CM or estrogen
treatment attenuated apoptotic cell death, astrogliosis, activated
inﬂammation, and oxidative stress in injured spinal cord to
improve locomotor function of the SCI animals signiﬁcantly. In
addition, the beneﬁcial effects exerted by the combined therapy
(CM and estrogen) are superior to those of CM or estrogen treat-
ment alone in SCI. It appears that adjunct CM and estrogen therapy
is a promising strategy for treatment of SCI. Adjunct CM and 17b-
estradiol therapymaymodify the inﬂammatory environment in the
acute phase and attenuate the effects of the inhibitory scar tissue
(e.g., astrogliosis) in the subacute/chromic phase to provide a
permissive environment for axonal extension as well as functional
recovery after SCI [41].
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